STACEY HILL: Open Payments
NPI 1104108414 · MT OLIVE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,280 in 71 payments from 24 companies in 2025. Trend: 2023 $235 · 2024 $1,493 · 2025 $1,280
Food & beverage: $1,280
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $175 |
| Novo Nordisk Inc | 10 | $143 |
| Sumitomo Pharma America, Inc. | 5 | $92 |
| Aimmune Therapeutics, Inc. | 4 | $91 |
| Corcept Therapeutics | 4 | $80 |
| Astellas Pharma US Inc | 4 | $76 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $62 |
| ABBVIE INC. | 3 | $60 |
| TOLMAR, INC. | 3 | $55 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $53 |
Products named: AIRSUPRA, GEMTESA, ZENPEP, Korlym, Veozah, BREZTRI, Wegovy, XIFAXAN.
Industry payments across NC — which companies pay providers there.
